EHC

+ Watchlist + Portfolio

Encompass Health Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $121.74
52-Week Range: $92.77 – $127.99
Market Cap: $11.93B
P/E (TTM): 20.19
EPS (TTM): 5.99
Dividend Yield: 0.69%

Advanced Metrics

Price/Book: 4.60
PEG Ratio: 0.41
Return on Equity: 24.97%
Return on Assets: 9.80%
Gross Margin: 43.86%
Operating Margin: 18.05%
Profit Margin: 10.01%
Current Ratio: 1.19
Debt/Equity: 0.82
Total Debt: $2.84B
Free Cash Flow: $229.92M
Revenue Growth: 9.60%
Earnings Growth: 10.80%
Enterprise Value: $15.61B

EHC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$4.35B	$4.80B	$5.37B	$5.94B
Cost of Revenue	$2.60B	$2.82B	$3.14B	$254.40M
Gross Profit	$1.75B	$1.98B	$2.23B	$5.68B
Selling, General & Admin	$209.00M	$258.00M	$266.50M	$3.41B
Operating Expenses	$1.12B	$1.25B	$1.37B	$4.63B
Operating Income	$630.20M	$731.80M	$864.50M	$1.05B
EBITDA	$870.10M	$1.02B	$1.19B	$1.40B
Pretax Income	$450.80M	$607.20M	$749.60M	$953.00M
Income Tax	$100.10M	$132.20M	$150.20M	$192.90M
Net Income	$271.00M	$352.00M	$455.70M	$566.20M
Diluted EPS	2.70	3.47	4.46	5.54
Diluted Shares	100.40M	101.30M	102.20M	102.20M

EHC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$21.80M	$69.10M	$85.40M	$72.20M
Receivables	$536.80M	$611.60M	$598.80M	$619.20M
Current Assets	$717.20M	$841.80M	$886.90M	$905.90M
Total Assets	$5.64B	$6.10B	$6.53B	$7.09B
Current Liabilities	$575.90M	$656.40M	$841.00M	$836.40M
Long-Term Debt	$2.74B	$2.69B	$2.36B	$2.45B
Total Debt	$2.99B	$2.93B	$2.71B	$2.71B
Total Liabilities	$3.77B	$3.81B	$3.69B	$3.81B
Retained Earnings	$115.70M	$406.50M	$796.70M	$1.29B
Shareholders' Equity	$1.31B	$1.65B	$2.07B	$2.44B
Working Capital	$141.30M	$185.40M	$45.90M	$69.50M
Net Debt	$2.75B	$2.64B	$2.41B	$2.42B

EHC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$705.80M	$850.80M	$1.00B	$1.18B
Capital Expenditure	-$584.10M	-$583.10M	-$642.50M	-$736.40M
Free Cash Flow	$121.70M	$267.70M	$360.30M	$439.20M
Depreciation & Amortisation	$243.60M	$273.90M	$299.60M	$327.90M
Stock-Based Compensation	$29.20M	$50.60M	$48.30M	$56.50M
Investing Cash Flow	-$627.00M	-$602.80M	-$653.30M	-$764.60M
Financing Cash Flow	-$145.70M	-$197.20M	-$330.60M	-$431.20M
Dividends Paid	-$99.00M	-$60.40M	-$62.80M	-$71.10M
Share Repurchases	$0.00	$0.00	-$31.10M	-$158.00M
Net Change in Cash	-$66.90M	$50.80M	$18.90M	-$20.20M

EHC Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$1.46B	$1.46B	$1.48B	$1.54B	$1.59B
Cost of Revenue	$824.50M	$830.80M	$64.60M	$64.50M	$64.30M
Gross Profit	$630.90M	$626.90M	$1.41B	$1.48B	$1.52B
Selling, General & Admin	$67.20M	$74.10M	$855.80M	$884.00M	$891.50M
Operating Expenses	$363.90M	$367.80M	$1.17B	$1.20B	$1.22B
Operating Income	$267.00M	$259.10M	$243.60M	$283.40M	$301.60M
EBITDA	$349.60M	$347.10M	$333.10M	$374.30M	$407.80M
Pretax Income	$238.60M	$236.80M	$219.90M	$257.70M	$288.70M
Income Tax	$41.60M	$51.00M	$44.90M	$55.40M	$56.40M
Net Income	$151.50M	$142.10M	$126.50M	$146.10M	$194.50M
Diluted EPS	1.48	1.39	1.24	1.43	1.93
Diluted Shares	102.10M	102.30M	102.30M	102.00M	100.60M

EHC Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$95.80M	$99.10M	$48.70M	$72.20M	$110.50M
Receivables	$623.40M	$612.50M	$610.80M	$619.20M	$676.00M
Current Assets	$910.90M	$918.10M	$869.80M	$905.90M	$1.03B
Total Assets	$6.64B	$6.79B	$6.87B	$7.09B	$7.31B
Current Liabilities	$856.00M	$865.10M	$762.00M	$836.40M	$876.80M
Long-Term Debt	$2.33B	$2.32B	$2.39B	$2.45B	$2.53B
Total Debt	$2.70B	$2.69B	$2.66B	$2.71B	$2.79B
Total Liabilities	$3.70B	$3.70B	$3.68B	$3.81B	$3.95B
Retained Earnings	$930.80M	$1.06B	$1.16B	$1.29B	$1.46B
Shareholders' Equity	$2.16B	$2.28B	$2.37B	$2.44B	$2.52B
Working Capital	$54.90M	$53.00M	$107.80M	$69.50M	$152.30M
Net Debt	$2.38B	$2.36B	$2.38B	$2.42B	$2.46B

EHC Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$288.60M	$270.20M	$270.80M	$346.00M	$313.10M
Capital Expenditure	-$163.10M	-$156.90M	-$187.10M	-$229.30M	-$162.40M
Free Cash Flow	$125.50M	$113.30M	$83.70M	$116.70M	$150.70M
Depreciation & Amortisation	$79.20M	$79.90M	$82.40M	$86.40M	$87.30M
Stock-Based Compensation	$9.50M	$14.30M	$14.30M	$18.40M	$11.50M
Investing Cash Flow	-$158.50M	-$165.40M	-$201.30M	-$239.40M	-$150.10M
Financing Cash Flow	-$130.40M	-$90.20M	-$113.20M	-$97.40M	-$102.50M
Dividends Paid	-$18.00M	-$17.10M	-$17.00M	-$19.00M	-$20.30M
Share Repurchases	-$32.10M	-$24.70M	-$24.90M	-$76.30M	-$71.60M
Net Change in Cash	-$300.00K	$14.60M	-$43.70M	$9.20M	$60.50M

Market Snapshot

About

Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States. The company operates over 150 hospitals across 37 states and Puerto Rico, providing intensive physical rehabilitation services for patients recovering from stroke, brain injury, spinal cord injury, complex orthopedic conditions and other debilitating illnesses or injuries. Encompass Health also offers home health and hospice services through a separate segment. The company focuses on post-acute care designed to help patients regain functional abilities and return home.